Remediation Sciences and Technology supplies some of the world's largest CPG and cannabis companies with cannabis extracts RST will provide…
News in SummaryCloud DX insiders (as defined by the TSX Venture Exchange) holding approximately 33% of the issued and outstanding…
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 17, 2022 / CureVac N.V. (NASDAQ:CVAC), a global biopharmaceutical company developing…
IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film, microneedle patch and biosynthesis…
MARKHAM, Ontario, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has…
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill 500 UK patients to be treated as…
CLC invites individual and institutional investors, as well as advisors and analysts, to attend our interactive presentation real-time on VirtualInvestorConferences.comVANCOUVER,…
VICTORIA, British Columbia, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil” or the “Company”) (TSXV: VGL) announced…
CAMBRIDGE, Mass., Jan. 17, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing SINTAX™ medicines…
MELBOURNE, Australia, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on…